{
    "data": [
        {
            "id": "DJN_DN20260226019495_20260226019495:0",
            "title": "Malayan Banking Target Price Raised to MYR13.30 From MYR12.40 by TA Securities >1155.KU",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019495_20260226019495:0/",
            "pub_date": "2026-02-27 09:16:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2940881:0",
            "title": "MMI: Record profit and revenue growth achieved, with strong cash flow and share buy-back approved",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Record bauxite shipments and a 23% revenue increase drove a $142.3 million net profit, reversing last year’s loss. Operational improvements, impairment reversal, and strong cash flow supported a positive outlook, with debt maturity extended and a share buy-back approved.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2940881-95469b385b5f02ba5d81afc89f47ff44\" target=\"_blank\">Metro Mining Limited [MMI] Annual Report — Feb. 27 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2940881:0-mmi-record-profit-and-revenue-growth-achieved-with-strong-cash-flow-and-share-buy-back-approved/",
            "pub_date": "2026-02-27 09:17:09",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN05M:0",
            "title": "Biodesix Inc reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Biodesix Inc </span><span> reported a quarterly adjusted loss of 49 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.20.  The mean expectation of five analysts for the quarter was for a loss of 85 cents per share. Wall Street expected results to range from $-1.05 to -63 cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue rose 23.1% to $25.15 million from a year ago; analysts expected $25.73 million. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Biodesix Inc's reported EPS for the quarter was a loss of 49 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported a quarterly loss of $3.98 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Biodesix Inc shares had risen by 90.1% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had risen by about 6.3% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Biodesix Inc is $35.00, about 59.4% above its last closing price of $14.22</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:17 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>-0.85</span></p></td><td><p class=\"\"><span>-0.49</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>-1.44</span></p></td><td><p class=\"\"><span>-1.16</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>-1.37</span></p></td><td><p class=\"\"><span>-1.60</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>-1.36</span></p></td><td><p class=\"\"><span>-1.60</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN05M:0-biodesix-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:17:26",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZN025:0",
            "title": "Denver mayor orders protection of protesters, ban on ICE from city property",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>By Kanishka Singh</span></p><p class=\"\"><span>    Denver Mayor Mike Johnston signed an order on Thursday authorizing the Democratic-governed city's police to protect peaceful protesters against federal Immigration and Customs Enforcement operations and banning ICE from city property.</span></p><p class=\"\"><span>Republican President </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.reuters.com/world/us/donald-trump/\" rel=\"nofollow\" target=\"_blank\">Donald Trump's</a><span> administration has used ICE in an immigration crackdown that has been condemned by human rights advocates, especially after the January fatal shootings of two U.S. citizens by federal agents in Minnesota.</span></p><p class=\"\"><span>In the aftermath of those shootings, Democratic mayors and governors have sought ways to counter Trump's actions. </span></p><p class=\"\"><span>Minneapolis Mayor Jacob Frey signed an order prohibiting agencies from using any city-owned parking lots, ramps, garages, or vacant lots to stage immigration enforcement operations.</span></p><p class=\"\"><span>Johnston's order says that in the event of civil immigration enforcement operations, including a surge in ICE agents, the city's law enforcement agencies \"shall use their established de-escalation protocols to try to protect peaceful protestors\" and ensure public health, safety, and the preservation of free speech rights.</span></p><p class=\"\"><span>\"If we see any ICE officer using excessive force against a Denver resident, we will step in to detain that officer and remove them from the situation,\" Johnston said in a news conference about the order. </span></p><p class=\"\"><span>\"We hold our own officers to that standard, and we will hold any ICE agent to the same,\" he added.</span></p><p class=\"\"><span>The White House said local officials should work with ICE and not against it. \"Anyone doing otherwise is simply doing the bidding of criminal illegal aliens,\" White House spokeswoman Abigail Jackson said in a statement cited by Politico. </span></p><p class=\"\"><span>Trump has cast his crackdown as aiming to curb illegal immigration and improve domestic security. He has also threatened Democratic cities and states with federal funding freeze. </span></p><p class=\"\"><span>Rights groups say the crackdown has created a fearful environment for both citizens and immigrants, while violating due process and free speech rights.    </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZN025:0-denver-mayor-orders-protection-of-protesters-ban-on-ice-from-city-property/",
            "pub_date": "2026-02-27 09:17:42",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L6N3ZN01Y:0",
            "title": "Argentina's YPF posts $649 million quarterly loss; 42% jump in shale output",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>    Argentine state energy firm YPF </span><span> posted a fourth-quarter net loss of $649 million, more than double the $284 million loss it reported a year earlier due to shifting prices in oil and petroleum derivatives and a slowdown in gas sales, the company said. </span></p><p class=\"\"><span>The company's revenues fell 4% year-on-year, landing at $4.56 billion.</span></p><p class=\"\"><span>Quarterly adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) - a key measure of industry profitability - hit $1.28 billion, up 53% from a year earlier and surpassing the $1.22 billion estimate of analysts polled by LSEG.</span></p><p class=\"\"><span>Revenues for the final three months of the year dropped 4% versus the same period last year to $4.56 billion, also beating analysts' $4.11 billion forecast.</span></p><p class=\"\"><span>The company said its total shale oil production surged 35% year-on-year to an average of 165,000 barrels per day, while fourth-quarter shale production jumped 42% year-on-year to 196,000 barrels per day. </span></p><p class=\"\"><span>YPF's performance is a critical indicator for Argentina's economy, which relies on the company's Vaca Muerta operations in its push to become a net energy exporter, bolster dollar reserves and maintain a stable currency.</span></p><p class=\"\"><span>Earlier this month, analysts predicted that Vaca Muerta would help lift Argentina's energy surplus to a new record this year, predicting a trade surplus of up to $10 billion that would depend largely on the South American nation's oil output.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L6N3ZN01Y:0-argentina-s-ypf-posts-649-million-quarterly-loss-42-jump-in-shale-output/",
            "pub_date": "2026-02-27 09:19:38",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019508:0",
            "title": "Japan Offering Y4.7T Of TD-Bills (No 1365)",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>TOKYO--Japan's Ministry of Finance said Friday it is auctioning Y4.7 trillion of treasury discount bills.</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>Issue                  TD-Bill (Number 1365) </span><br/><span>Settlement Date                  Mar 2, 2026 </span><br/><span>Maturity Date                    Jun 1, 2026 </span><br/><span>Offer Amount                   Y4.7 Trillion </span></pre><p class=\"\"><span>This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019508:0/",
            "pub_date": "2026-02-27 09:20:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019506:0",
            "title": "Japan MOF To Auction Y4.7T Of TD-Bills Mar 6",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>TOKYO--Japan's Ministry of Finance said Friday it plans to auction Y4.7 trillion of treasury discount bills on Mar. 6, 2026.</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>Issue                        TD-Bill </span><br/><span>Auction Date             Mar 6, 2026 </span><br/><span>Settlement Date          Mar 9, 2026 </span><br/><span>Maturity Date            Jun 8, 2026 </span><br/><span>Offer Amount           Y4.7 Trillion </span></pre><p class=\"\"><span>This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019506:0/",
            "pub_date": "2026-02-27 09:20:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:181cfbfd46a8a:0",
            "title": "ImmunityBio Director Sells 75,000 Shares",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>ImmunityBio Director, Simon Barry J., sold 75,000 shares of Common Stock on February 24, 2026, at a weighted average price of $12.0105 per share, totaling $900,787. The sale was conducted under a Rule 10b5-1 trading plan adopted on September 4, 2024. Following the transaction, Simon Barry J. directly owns 2,850,821 shares of ImmunityBio.</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><span>Reporter Name</span></td><td><span>Simon Barry J.</span></td></tr><tr><td><span>Relationship</span></td><td><span>Director</span></td></tr><tr><td><span>Type</span></td><td><span>Sell</span></td></tr><tr><td><span>Amount</span></td><td><span>$900,787</span></td></tr><tr><td><span>SEC Filing</span></td><td><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000006/xslF345X05/wk-form4_1772154743.xml\" rel=\"nofollow\" target=\"_blank\">Form 4</a></td></tr></tbody></table></div><p class=\"\"><span>SEC Filing: </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.sec.gov/Archives/edgar/data/1647994/000164799426000006/xslF345X05/wk-form4_1772154743.xml\" rel=\"nofollow\" target=\"_blank\">ImmunityBio, Inc. [ IBRX ] - Form 4 - Feb. 26, 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:181cfbfd46a8a:0-immunitybio-director-sells-75-000-shares/",
            "pub_date": "2026-02-27 09:20:00",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2940864:0",
            "title": "BUB: Strong U.S. and China growth drove 14% revenue increase, with margins above guidance",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Revenue rose 14% year-over-year, led by U.S. expansion and strong China performance. Gross margin exceeded guidance despite air freight and tariff costs, with FY26 revenue expected to grow 22–27%. Focus remains on core products, digital marketing, and operational efficiency.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2940864:0-bub-strong-u-s-and-china-growth-drove-14-revenue-increase-with-margins-above-guidance/",
            "pub_date": "2026-02-27 09:10:04",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019470:0",
            "title": "Goldman Sachs BDC, Inc. Reports December 31, 2025 Financial Results and Announces First Quarterly 2026 Base Dividend of $0.32 Per Share and Fourth Quarter 2025 Supplemental Dividend of $0.03 Per Share.",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>NEW YORK--(BUSINESS WIRE)--February 26, 2026--</span></p><p class=\"\"><span>Goldman Sachs BDC, Inc. (\"GSBD\", the \"Company\", \"we\", \"us\", or \"our\") </span><span> today reported financial results for the fourth quarter and year ended December 31, 2025 and filed its Form 10-K with the U.S. Securities and Exchange Commission.</span></p><p class=\"\"><span>QUARTERLY HIGHLIGHTS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Net investment income and adjusted net investment income per share for   the quarter ended December 31, 2025 was $0.37, equating to an annualized   net investment income yield on book value of 11.7%.1 Earnings per share   for the quarter ended December 31, 2025 was $0.21.   </span></li><li class=\"listItem-bmN0_SHH\"><span>Net asset value (\"NAV\") per share as of December 31, 2025 decreased   0.9% to $12.64 from $12.75 as of September 30, 2025.   </span></li><li class=\"listItem-bmN0_SHH\"><span>As of December 31, 2025, the Company's total investments at fair value   and commitments were $3,898.2 million, comprised of investments in 171   portfolio companies across 40 industries. The investment portfolio was   comprised of 98.4% senior secured debt, including 96.9% in first lien   investments.   </span></li><li class=\"listItem-bmN0_SHH\"><span>During the quarter, the Company had new investment commitments of   approximately $394.9 million of which $230.2 million were funded.   Fundings of previously unfunded commitments for the quarter were $90.9   million and sales and repayments activity totaled $251.6 million,   resulting in net funded investment activity of $69.5 million.   </span></li><li class=\"listItem-bmN0_SHH\"><span>During the quarter, the Company's 1st Lien/Senior Secured Debt position   in Pluralsight, Inc. was placed on non-accrual status due to financial   underperformance. As of December 31, 2025, the Company had certain   investments held in nine portfolio companies on non-accrual status. As of   December 31, 2025, investments on non-accrual status amounted to 1.9% and   2.8% of the total investment portfolio at fair value and amortized cost,   respectively.   </span></li><li class=\"listItem-bmN0_SHH\"><span>The Company's ending net debt-to-equity ratio was 1.27x as of December   31, 2025 compared to 1.17x as of September 30, 2025.   </span></li><li class=\"listItem-bmN0_SHH\"><span>As of December 31, 2025, 68.9% of the Company's approximately $1,885.8   million aggregate principal amount of debt outstanding was comprised of   unsecured debt and 31.1% was comprised of secured debt.3   </span></li><li class=\"listItem-bmN0_SHH\"><span>On January 15, 2026, the Company borrowed approximately $505.0 million   under the Truist Revolving Credit Facility and used the proceeds,   together with cash on hand, to repay the 2026 Notes plus accrued and   unpaid interest. On January 28, 2026, the Company also closed an offering   of $400.0 million aggregate principal amount of 5.100% unsecured notes   due 2029.   </span></li><li class=\"listItem-bmN0_SHH\"><span>The Company's Board of Directors declared a first quarter 2026 Base   Dividend of $0.32 per share payable to shareholders of record as of March   31, 2026.4   </span></li><li class=\"listItem-bmN0_SHH\"><span>The Company's Board of Directors also declared a fourth quarter 2025   Supplemental Dividend of $0.03 per share payable on or about March 20,   2026 to shareholders of record as of March 9, 2026. Adjusted for the   impact of the Supplemental Dividend related to the fourth quarter's   earnings, the Company's fourth quarter adjusted NAV per share was   $12.61.5   </span></li><li class=\"listItem-bmN0_SHH\"><span>On June 13, 2025, the Company entered into a 10b5-1 stock repurchase   plan, which allows the Company to repurchase up to $75.0 million of   shares of the Company's common stock if the common stock trades below the   most recently announced quarter-end NAV per share, subject to certain   limitations. During the three months ended December 31, 2025, the Company   repurchased 1,544,029 shares for $15.0 million, inclusive of commission   and direct acquisition costs. </span></li></ul><p class=\"\"><span>SELECTED FINANCIAL HIGHLIGHTS</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>(in $ millions, except per          As of                  As of </span><br/><span>share data)                    December 31, 2025     September 30, 2025 </span><br/><span>Investment portfolio, at </span><br/><span> fair value(2)               $            3,261.7  $             3,196.9 </span><br/><span>Total debt outstanding(3)    $            1,885.8  $             1,853.0 </span><br/><span>Net assets                   $            1,423.0  $             1,454.8 </span><br/><span>Ending net debt to </span><br/><span>equity(11)                                  1.27x                  1.17x </span><br/><span>Net asset value per share    $              12.64  $               12.75 </span><br/><span>   Less: Supplemental </span><br/><span>    Dividend per share </span><br/><span>    declared post-quarter    $               0.03  $                0.04 </span><br/><span>Adjusted net asset value </span><br/><span> per share(5)                $              12.61  $               12.71 </span><br/><span> </span><br/><span> </span><br/><span>(in $ millions, except      Three Months Ended     Three Months Ended </span><br/><span>per share data)              December 31, 2025      September 30, 2025 </span><br/><span>Total investment income    $               86.1   $                91.6 </span><br/><span> </span><br/><span>Net investment income </span><br/><span> after taxes               $               42.2   $                45.3 </span><br/><span>   Less: Purchase </span><br/><span>    discount </span><br/><span>    amortization           $                0.4                     0.5 </span><br/><span>   Adjusted net </span><br/><span>    investment income </span><br/><span>    after taxes(1)         $               41.8   $                44.8 </span><br/><span> </span><br/><span>Net realized and </span><br/><span> unrealized gains </span><br/><span> (losses)                  $              (18.5)  $               (20.6) </span><br/><span>   Add: </span><br/><span>    Realized/Unrealized </span><br/><span>    depreciation from the </span><br/><span>    purchase discount                       0.4                     0.5 </span><br/><span>   Adjusted net realized </span><br/><span>    and unrealized gains </span><br/><span>    (losses)(1)            $              (18.1)  $               (20.1) </span><br/><span> </span><br/><span>Net investment income per </span><br/><span> share (basic and </span><br/><span> diluted)                  $               0.37   $                0.40 </span><br/><span>   Less: Purchase </span><br/><span>   discount amortization </span><br/><span>   per share               $                 --                      -- </span><br/><span>   Adjusted net </span><br/><span>    investment income per </span><br/><span>    share(1)               $               0.37   $                0.40 </span><br/><span> </span><br/><span>Weighted average shares </span><br/><span> outstanding                              113.5                   114.4 </span><br/><span>Total Quarterly </span><br/><span> Distributions per share   $               0.36   $                0.51 </span><br/><span> </span></pre><p class=\"\"><span>Total investment income for the three months ended December 31, 2025 and September 30, 2025 was $86.1 million and $91.6 million, respectively. The decrease in total investment income was primarily due to a decline in base interest rates and tightening of credit spreads.</span></p><p class=\"\"><span>Net expenses before taxes for the three months ended December 31, 2025 and September 30, 2025 were $43.0 million and $45.4 million, respectively. Net expenses decreased by $2.4 million, primarily driven by a decrease in incentive fees, partially offset by higher interest and other debt expenses.</span></p><p class=\"\"><span>INVESTMENT ACTIVITY(2)</span></p><p class=\"\"><span>The following table summarizes investment activity for the three months ended December 31, 2025:</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>                     New Investment </span><br/><span>                       Commitments             Sales and Repayments </span><br/><span>                 -----------------------      ----------------------- </span><br/><span>Investment </span><br/><span>Type             $ Millions   % of Total      $ Millions   % of Total </span><br/><span>--------------   -----------  ----------      -----------  ---------- </span><br/><span>1st Lien/Senior </span><br/><span> Secured Debt    $     330.6        83.7%     $     237.0        94.2% </span><br/><span>1st </span><br/><span> Lien/Last-Out </span><br/><span> Unitranche             64.3        16.3             14.6         5.8 </span><br/><span>2nd </span><br/><span>Lien/Senior </span><br/><span>Secured Debt              --          --               --          -- </span><br/><span>Unsecured Debt            --          --               --          -- </span><br/><span>Preferred </span><br/><span>Stock                     --          --               --          -- </span><br/><span>Common Stock              --          --               --          -- </span><br/><span>                  ----------  ----------       ----------  ---------- </span><br/><span>   Total         $     394.9       100.0%     $     251.6       100.0% </span><br/><span>                  ----------  ----------       ----------  ---------- </span><br/><span> </span></pre><p class=\"\"><span>During the three months ended December 31, 2025, new investment commitments were across 7 new portfolio companies and 20 existing portfolio companies. Sales and repayments were primarily driven by the exit and refinancing of our investments in 13 portfolio companies.</span></p><p class=\"\"><span>PORTFOLIO SUMMARY(2)</span></p><p class=\"\"><span>As of December 31, 2025, the Company's investments consisted of the following:</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>                                  Investments at Fair Value </span><br/><span>                                ------------------------------ </span><br/><span>Investment Type                     $ Millions      % of Total </span><br/><span>-----------------------------   ------------------  ---------- </span><br/><span>1st Lien/Senior Secured Debt    $          3,028.8        92.8% </span><br/><span>1st Lien/Last-Out Unitranche                 135.1         4.1 </span><br/><span>2nd Lien/Senior Secured Debt                  47.9         1.5 </span><br/><span>Unsecured Debt                                 8.5         0.3 </span><br/><span>Preferred Stock                               26.4         0.8 </span><br/><span>Common Stock                                  14.7         0.5 </span><br/><span>Warrants                                       0.3      -- (6) </span><br/><span>                                ----  ------------  ---------- </span><br/><span>   Total                        $          3,261.7       100.0% </span><br/><span>                                ----  ------------  ---------- </span><br/><span> </span></pre><p class=\"\"><span>The following table presents certain selected information regarding the Company's investments:</span></p><pre class=\"preformatted-zagxxLT_\" data-no-swipe=\"true\"><span> </span><br/><span>                                           As of </span><br/><span>                         ----------------------------------------- </span><br/><span>                         December 31, 2025       December 31, 2024 </span><br/><span>                         -----------------       ----------------- </span><br/><span>Number of portfolio </span><br/><span> companies                             171                     164 </span><br/><span>Percentage of </span><br/><span> performing debt </span><br/><span> bearing a floating </span><br/><span> rate(7)                              99.4%                   99.4% </span><br/><span>Percentage of </span><br/><span> performing debt </span><br/><span> bearing a fixed </span><br/><span> rate(7)                               0.6%                    0.6% </span><br/><span>Weighted average yield </span><br/><span> on debt and income </span><br/><span> producing </span><br/><span> investments, at </span><br/><span> amortized cost(8)                     9.9%                   11.2% </span><br/><span>Weighted average yield </span><br/><span> on debt and income </span><br/><span> producing </span><br/><span> investments, at fair </span><br/><span> value(8)                             10.9%                   14.1% </span><br/><span>Weighted average </span><br/><span>leverage (net </span></pre></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019470:0/",
            "pub_date": "2026-02-27 09:11:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-27:newsml_PLX1AF77D:0",
            "title": "BRIEF-Goldman Sachs BDC Q4 EPS USD 0.21",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Feb 27 (Reuters) - Goldman Sachs BDC Q4 dividend USD 0.03.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-27:newsml_PLX1AF77D:0-brief-goldman-sachs-bdc-q4-eps-usd-0-21/",
            "pub_date": "2026-02-27 09:11:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN058:0",
            "title": "Intchains Group Ltd reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Intchains Group Ltd </span><span> reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 2 cents.  The mean expectation of two analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -1 cents tozero cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue fell 49.2% to $5.17 million from a year ago; analysts expected $6.03 million. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Intchains Group Ltd's reported EPS for the quarter was a loss of 15 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported a quarterly loss of $18.69 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Intchains Group Ltd shares had fallen by 23.5% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts was unchanged in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the blockchain &amp; cryptocurrency peer group is also \"buy\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Intchains Group Ltd is $3.50, about 61.7% above its last closing price of $1.34</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:12 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>0.00</span></p></td><td><p class=\"\"><span>-0.15</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>-0.01</span></p></td><td><p class=\"\"><span>0.18</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>0.06</span></p></td><td><p class=\"\"><span>0.08</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>0.11</span></p></td><td><p class=\"\"><span>-0.04</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN058:0-intchains-group-ltd-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:12:11",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN05H:0",
            "title": "RealReal Inc reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>RealReal Inc </span><span> reported quarterly adjusted earnings of 6 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -1 cents.  The mean expectation of nine analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 3 cents to 5 cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue rose 18.3% to $194.05 million from a year ago; analysts expected $190.70 million. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>RealReal Inc's reported EPS for the quarter was a loss of 33 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported a quarterly loss of $38.78 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>RealReal Inc shares had fallen by 23.8% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had risen by about 17.3% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, there have been no negative revisions of earnings estimates</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 7 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the department stores peer group is also \"buy\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for RealReal Inc is $18.00, about 31.2% above its last closing price of $12.39</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>0.04</span></p></td><td><p class=\"\"><span>0.06</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>-0.06</span></p></td><td><p class=\"\"><span>-0.04</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>-0.08</span></p></td><td><p class=\"\"><span>-0.06</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>-0.08</span></p></td><td><p class=\"\"><span>-0.08</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN05H:0-realreal-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:13:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN05I:0",
            "title": "Coupang Inc reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Coupang Inc </span><span> reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 4 cents.  The mean expectation of eight analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 1 cents to 4 cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue rose 16.3% to $8.84 billion from a year ago; analysts expected $9.05 billion. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Coupang Inc's reported EPS for the quarter was 5 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported a quarterly loss of $26 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Coupang Inc shares had fallen by 22.2% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had fallen by about 32.4% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, three analysts negatively revised earnings estimates</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 12 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the department stores peer group is also \"buy\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Coupang Inc is $31.00, about 39.6% above its last closing price of $18.71</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>0.03</span></p></td><td><p class=\"\"><span>0.05</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>0.06</span></p></td><td><p class=\"\"><span>0.05</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>0.06</span></p></td><td><p class=\"\"><span>0.02</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>0.05</span></p></td><td><p class=\"\"><span>0.06</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN05I:0-coupang-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:13:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019490:0",
            "title": "Net Proceeds to Kratos From the Offering Expected to Be Approximately $1.2B >KTOS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019490:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019489:0",
            "title": "Kratos: Underwritten Offering of 14.3M Shares Priced at $84.00 Each >KTOS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019489:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019493:0",
            "title": "Kratos: Net Proceeds for Capital Expenditures, Investments, Strengthen Balance Sheet, Fund Nomad Acquisition, General Corporate Purposes >KTOS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019493:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019491:0",
            "title": "Kratos: Granted Underwriters 30-Day Option to Purchase Up to Additional 2.1M Shares >KTOS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019491:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019488:0",
            "title": "Kratos Defense & Security Solutions Prices Public Offering of Common Stock",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019488:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019431_20260226019492:0",
            "title": "All Shares in Offering Are to Be Sold by Kratos >KTOS",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019431_20260226019492:0/",
            "pub_date": "2026-02-27 09:15:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_TUA3PK8JQ:0",
            "title": "Wescan Goldfields Inc. Announces Management Changes And Stock Option Grant",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Wescan Goldfields Inc </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>WESCAN GOLDFIELDS INC. ANNOUNCES MANAGEMENT CHANGES AND STOCK OPTION GRANT</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>WESCAN GOLDFIELDS INC - APPOINTS W. CONNOR MACNEILL AS PRESIDENT AND CEO</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>WESCAN GOLDFIELDS INC - APPOINTS JEFF SHEPPARD AS CHIEF FINANCIAL OFFICER</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_TUA3PK8JQ:0-wescan-goldfields-inc-announces-management-changes-and-stock-option-grant/",
            "pub_date": "2026-02-27 09:15:06",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2940859:0",
            "title": "BRL: EBITDA and profit fell on lower prices and higher costs, but cash reserves and guidance remain strong",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Revenue and EBITDA declined year-over-year due to lower coal prices and higher costs, but cash reserves remain strong after a capital raise. Guidance for FY 2026 is maintained, with stable operations, ongoing project development, and a focus on shareholder returns.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2940859:0-brl-ebitda-and-profit-fell-on-lower-prices-and-higher-costs-but-cash-reserves-and-guidance-remain-strong/",
            "pub_date": "2026-02-27 09:05:51",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-27:newsml_ObikyCtZa:0",
            "title": "Grant of Stock Options",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>February 27, 2026</span></p><p class=\"\"><span>ZENITH ENERGY LTD.</span></p><p class=\"\"><span>(\"Zenith\" or the \"Company\")</span></p><p class=\"\"><span>Grant of Stock Options</span></p><p class=\"\"><span>Zenith Energy Ltd. (\"Zenith\" or the \"Company\") (LSE: ZEN; OSE: ZENA; XSAT:ZENASDR), the listed international energy production and development company,announces that it has granted a total of 29,031,131 stock options (the\"Options\") to certain Directors and employees of the Company in accordancewiththe Company's Stock Option Plan.</span></p><p class=\"\"><span>The Options have an exercise price of NOK 0.44 per Option (approximatelyequivalent to £0.034 or 0.42 SEK), are fully vested and have a duration offiveyears from the date of issue.</span></p><p class=\"\"><span>Further Information:</span></p><p class=\"\"><span>Zenith Energy Ltd</span></p><p class=\"\"><span>Andrea Cattaneo, Chief Executive Officer</span></p><p class=\"\"><span>Tel: +1 (587) 315 1279</span></p><p class=\"\"><span>E:     info@zenithenergy.ca</span></p><p class=\"\"><span>Notes to Editors:</span></p><p class=\"\"><span>Zenith Energy Ltd. is a revenue generating, independent energy company with</span><br/><span>energy production, exploration and development assets in North Africa, the US</span><br/><span>and Europe. The Company is listed on the London Stock Exchange Main Market</span><br/><span>, the Euronext Growth of the Oslo Stock Exchange (OSE: ZENA) and on the</span><br/><span>Spotlight Stock Market in Sweden (XSAT: ZENA SDR).</span></p><p class=\"\"><span>Zenith's strategic focus is on pursuing development opportunities through thedevelopment of proven revenue generating energy production assets, as well aslow-risk exploration activities in assets with existing production.</span></p><p class=\"\"><span>For more information, please visit: www.zenithenergy.ca</span></p><p class=\"\"><span>Twitter: @zenithenergyltd</span></p><p class=\"\"><span>LinkedIn: https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F10818980%2Fadmin%2F</span></p><p class=\"\"><span>Market Abuse Regulation (MAR) Disclosure</span></p><p class=\"\"><span>This information is subject to the disclosure requirements of Article 17 oftheEU Market Abuse Regulation(\"MAR\"). The information was authorised for publication by the contact person.</span></p><p class=\"\"><span>NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGINGMANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.</span></p><p class=\"\"><span>1      Details of the person discharging managerial responsibilities / personcloselyassociateda)     Name    Andrea Cattaneo2      Reason for the notificationa)     Position/status Chief Executive Officer &amp; Presidentb)     Initial notification/Amendment  Initial Notification3      Details of the issuer, emission allowance market participant, auctionplatform, auctioneer or auction monitora)     Name    Zenith Energy Ltd.b)     LEI     213800AYTYOYD61S45694      Details of the transaction(s): section to be repeated for (i) each typeofinstrument; (ii) each type of transaction; (iii) each date; and (iv) eachplacewhere transactions have been conducteda)     Description of the financial instrument, type of instrument</span></p><p class=\"\"><span>Options for common shares of no par value in Zenith Energy Ltd.       Identification code     CA98936C8584b)     Nature of the transaction       Grant of Stock Options in accordancewith StockOption Planc)     Price(s) and volumes(s) Price(s)        Volume(s)               NOK 0.44        16,838,056d)     Date of the transaction(s)      February 27, 2026e)     Place of the transaction        Off Market 1      Details of the person discharging managerial responsibilities / personcloselyassociateda)     Name    Luca Benedetto2      Reason for the notificationa)     Position/status Chief Financial Officer and Executive Directorb)     Initial notification/Amendment  Initial Notification3      Details of the issuer, emission allowance market participant, auctionplatform, auctioneer or auction monitora)     Name    Zenith Energy Ltd.b)     LEI     213800AYTYOYD61S45694      Details of the transaction(s): section to be repeated for (i) each typeofinstrument; (ii)each type of transaction; (iii) each date; and (iv) each place wheretransactions have been conducteda)     Description of the financial instrument, type of instrument</span></p><p class=\"\"><span>Options for common shares of no par value in Zenith Energy Ltd.       Identification code     CA98936C8584b)     Nature of the transaction       Grant of Stock Options in accordancewith StockOption Planc)     Price(s) and volumes(s) Price(s)        Volume(s)               NOK 0.44        2,903,113d)     Date of the transaction(s)      February 27, 2026e)     Place of the transaction        Off Market 1      Details of the person discharging managerial responsibilities / personcloselyassociateda)     Name    Sergey Borovskiy Alexandrovich2      Reason for the notificationa)     Position/status Non-Executive Directorb)     Initial notification/Amendment  Initial Notification3      Details of the issuer, emission allowance market participant, auctionplatform, auctioneer or auction monitora)     Name    Zenith Energy Ltd.b)     LEI     213800AYTYOYD61S45694      Details of the transaction(s): section to be repeated for (i) each typeofinstrument; (ii)each type of transaction; (iii) each date; and (iv) each place wheretransactions have been conducteda)     Description of the financial instrument, type of instrument</span></p><p class=\"\"><span>Options for common shares of no par value in Zenith Energy Ltd.       Identification code     CA98936C8584b)     Nature of the transaction       Grant of Stock Options in accordancewith StockOption Planc)     Price(s) and volumes(s) Price(s)        Volume(s)               NOK 0.44        1,451,557d)     Date of the transaction(s)      February 27, 2026e)     Place of the transaction        Off Market</span></p><p class=\"\"><span>https://newsweb.oslobors.no/message/667033</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-27:newsml_ObikyCtZa:0-grant-of-stock-options/",
            "pub_date": "2026-02-27 09:06:15",
            "source": "Oslo Stock Exchange",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN04M:0",
            "title": "OPKO Health Inc reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>OPKO Health Inc </span><span> reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -9 cents.  The mean expectation of seven analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -9 cents to -5 cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue fell 19.1% to $151.70 million from a year ago; analysts expected $139.76 million. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>OPKO Health Inc shares had fallen by 6.3% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had fallen by about 52.4% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, three analysts negatively revised earnings estimates</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for OPKO Health Inc is $3.00, about 60% above its last closing price of $1.20</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:06 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>-0.04</span></p></td><td><p class=\"\"><span>-0.04</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>-0.04</span></p></td><td><p class=\"\"><span>0.03</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>-0.11</span></p></td><td><p class=\"\"><span>-0.19</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>-0.07</span></p></td><td><p class=\"\"><span>-0.10</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN04M:0-opko-health-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:06:25",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN04N:0",
            "title": "Brinks Co reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Brinks Co </span><span> reported quarterly adjusted earnings of $2.08​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $1.51.  The mean expectation of three analysts for the quarter was for earnings of $2.47 per share. Wall Street expected results to range from $2.46  to $2.12 per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue rose 5.6% to $1.38 billion from a year ago; analysts expected $1.35 billion. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Brinks Co's reported EPS for the quarter was 86 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported quarterly net income of $68.4 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Brinks Co shares had risen by 11.0% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had risen by about 18.7% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, three analysts negatively revised earnings estimates</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the business support services peer group is also \"buy\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Brinks Co is $146.00, about 7.1% above its last closing price of $135.58</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:06 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>2.08</span></p></td><td><p class=\"\"><span>2.08</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>2.08</span></p></td><td><p class=\"\"><span>2.08</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>1.45</span></p></td><td><p class=\"\"><span>1.79</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>1.17</span></p></td><td><p class=\"\"><span>1.62</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN04N:0-brinks-co-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:06:39",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226019457_20260226019457:0",
            "title": "WiseTech Global Price Target Cut 40% to A$65.35/Share by Citi",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226019457_20260226019457:0/",
            "pub_date": "2026-02-27 09:08:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZN012:0",
            "title": "Zscaler posts wider quarterly loss on higher spending; shares down 9%",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>By Jaspreet Singh</span></p><p class=\"\"><span>    Zscaler </span><span> on Thursday posted a wider net loss in the second quarter, citing higher spending on sales, marketing, and research and development in a competitive market, sending shares of the cloud security firm down roughly 9% in extended trading.</span></p><p class=\"\"><span>The results come when IT budgets remain tight and clients spend cautiously on large deals amid economic uncertainty, even though cybersecurity budgets face less pressure than general capital outlays.</span></p><p class=\"\"><span>Zscaler provides cloud-based zero trust security, which is designed to eliminate the need for legacy firewalls and virtual private networks (VPNs) by authenticating each connection rather than granting broader network access.</span></p><p class=\"\"><span>Shares of cybersecurity companies, including CrowdStrike </span><span> and Zscaler, have fallen in recent days as investors assessed the potential impact of AI startup Anthropic's Claude Code Security tool on the industry.</span></p><p class=\"\"><span>Zscaler, which competes with Palo Alto Networks </span><span> and Cloudflare </span><span>, reported a net loss of $34.3 million in the quarter ended January 31, widening sharply from a net loss of $7.7 million a year earlier.</span></p><p class=\"\"><span>Total operating expenses rose to $676.3 million in the second quarter, compared with $539.5 million in the year-ago period, driven by sales, marketing and research and development expenses.</span></p><p class=\"\"><span>\"While CIOs (chief information officers) care about the budget, but they're doing two things. One, they do want to embrace AI. And two, they want to do it securely. So AI is driving demand for security,\" Zscaler CEO Jay Chaudhry said.</span></p><p class=\"\"><span>Businesses spend on tools offered by companies such as Zscaler amid a wave of high-profile cyberattacks that has hit companies, including F5 </span><span>.</span></p><p class=\"\"><span>Zscaler said its second-quarter revenue rose 26% to $815.8 million, beating analysts' average estimate of $798.8 million, according to LSEG-compiled data. Its adjusted profit per share of $1.01 exceeded estimate of 90 cents.</span></p><p class=\"\"><span>The company forecast third-quarter adjusted earnings per share of $1.00 to $1.01, above analysts' estimates of 95 cents, and revenue of $834 million to $836 million, topping expectations of $831.9 million.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZN012:0-zscaler-posts-wider-quarterly-loss-on-higher-spending-shares-down-9/",
            "pub_date": "2026-02-27 09:08:01",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L8N3ZN04P:0",
            "title": "American Healthcare REIT Inc reports results for the quarter ended December 31 - Earnings Summary",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>American Healthcare REIT Inc </span><span> reported quarterly adjusted earnings of 24 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -3 cents.  The mean expectation of six analysts for the quarter was for earnings of 16 cents per share. Wall Street expected results to range from 13 cents to 17 cents per share.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Revenue rose 9.4% to $572.94 million from a year ago; analysts expected $553.05 million. </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>American Healthcare REIT Inc's reported EPS for the quarter was 6 cents​.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The company reported quarterly net income of $55.93 million.</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>American Healthcare REIT Inc shares had risen by 12.5% this quarter.</span></p></li></ul><p class=\"\"><span>FORECAST CHANGES</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The mean earnings estimate of analysts had fallen by about 7.1% in the last three months.​ </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>In the last 30 days, one analyst negatively revised an earnings estimate</span></p></li></ul><p class=\"\"><span>RECOMMENDATIONS</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 12 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the specialized reits peer group is also \"buy\" </span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for American Healthcare REIT Inc is $55.00, about 3.3% above its last closing price of $53.19</span></p></li></ul><p class=\"\"><span>This summary was machine generated from LSEG data February 27 at 01:08 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:RefinitivNewsSupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>)</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>QUARTER ENDING</span></p></td><td><p class=\"\"><span>ESTIMATE </span></p></td><td><p class=\"\"><span>ACTUAL</span></p></td><td><p class=\"\"><span>BEAT, MET, MISSED</span></p></td></tr><tr><td><p class=\"\"><span>Dec. 31 2025 </span></p></td><td><p class=\"\"><span>0.46</span></p></td><td><p class=\"\"><span>0.46</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr><tr><td><p class=\"\"><span>Sep. 30 2025 </span></p></td><td><p class=\"\"><span>0.42</span></p></td><td><p class=\"\"><span>0.42</span></p></td><td><p class=\"\"><span>Met</span></p></td></tr><tr><td><p class=\"\"><span>Jun. 30 2025 </span></p></td><td><p class=\"\"><span>0.36</span></p></td><td><p class=\"\"><span>0.42</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Mar. 31 2025 </span></p></td><td><p class=\"\"><span>0.40</span></p></td><td><p class=\"\"><span>0.38</span></p></td><td><p class=\"\"><span>Missed</span></p></td></tr></tbody></table></div></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N3ZN04P:0-american-healthcare-reit-inc-reports-results-for-the-quarter-ended-december-31-earnings-summary/",
            "pub_date": "2026-02-27 09:08:15",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L6N3ZM1AR:0",
            "title": "Steve Cohen's Point72 hires veteran Castleton trader in commodities push, sources say",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>By Shariq Khan and Georgina McCartney</span></p><p class=\"\"><span>Steve Cohen-led hedge fund Point72 Asset Management has hired Ryan Sheffler as natural gas portfolio manager to build out its commodities trading desk, three sources told Reuters. </span></p><p class=\"\"><span>Point72, which has so far focused primarily on equities, is among a few large hedge funds yet to build a commodities business and has begun to push into the space in recent months. </span></p><p class=\"\"><span>The investment firm's rivals, including Citadel and Millennium, have reaped bumper profits driven by a period of extreme volatility in commodity prices due to a string of geopolitical upheavals since Russia's 2022 invasion of Ukraine.</span></p><p class=\"\"><span>Point72 in recent weeks hired Sheffler from Stamford, Connecticut-based energy trading firm Castleton Commodities International, where he was a cross-asset trader, three industry sources said. </span></p><p class=\"\"><span>Point72, which had around $45.7 billion worth of assets under management as of January this year, declined to comment. </span></p><p class=\"\"><span>Sheffler and Castleton did not immediately respond to requests for comment. </span></p><p class=\"\"><span>Sheffler will lead natural gas trading for Stamford, Connecticut-based Point72, the sources said. </span></p><p class=\"\"><span>Gas has been one of the brightest spots in the commodities trading industry, drawing strong investor interest due to expectations that data center and liquefied natural gas plant buildouts will lift demand. </span></p><p class=\"\"><span>Sheffler spent the past 14 years at Castleton Commodities International in Houston as a cross-commodities trader, according to his LinkedIn profile. He started his career at Goldman Sachs in New York as a power trader in 2007. </span></p><p class=\"\"><span>Point72 is likely to make more commodities-focused hires over the coming months, two sources said. Point72 has also begun deliberations to set up an office in Houston to house the potential new recruits in the heart of the U.S. energy industry, one of the sources said. </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L6N3ZM1AR:0-steve-cohen-s-point72-hires-veteran-castleton-trader-in-commodities-push-sources-say/",
            "pub_date": "2026-02-27 09:08:59",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZM204:0",
            "title": "Drug developer Generate Biomedicines raises $400 million in US IPO",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>Drug developer Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares at $16 each.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZM204:0-drug-developer-generate-biomedicines-raises-400-million-in-us-ipo/",
            "pub_date": "2026-02-27 09:09:31",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        }
    ]
}